Zobrazeno 1 - 10
of 19
pro vyhledávání: '"J. Giermek"'
Publikováno v:
Expert Opinion on Drug Safety. 22:111-114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::379fbef8af9054e4eb75ff7449dd844e
https://doi.org/10.1080/14740338.2023.2188189
https://doi.org/10.1080/14740338.2023.2188189
Autor:
Amanda W Pong, Jonathan Ross, Ivana Tyrlikova, Alexander J Giermek, Maya P Kohli, Yousef A Khan, Roger D Salgado, Pavel Klein
Publikováno v:
Expert opinion on emerging drugs. 27(1)
Despite the existence of over 30 anti-seizure medications (ASM), including 20 over the last 30 years, a third of patients with epilepsy remain refractory to treatment, with no disease-modifying or preventive therapies until very recently. The develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4213a0ec93fc0a2e53500ef79a14f8a
https://pubmed.ncbi.nlm.nih.gov/35341431
https://pubmed.ncbi.nlm.nih.gov/35341431
Autor:
Sileny Han, Manfred Kaufmann, Brigitte Rack, Alistair Ring, Nadia Harbeck, Tanja Fehm, Sabine C. Linn, J Giermek, Michael J. Halaska, M. Bontenbal, Volkmar Müller, Valentina Nekljudova, Mina Mhallem Gziri, Kristel Van Calsteren, Liesbeth Heyns, Sibylle Loibl, Gunter von Minckwitz, Frédéric Amant, Ben Van Calster, Miriam Lenhard, Pieter J. Westenend, B. Schlehe
Publikováno v:
lancet oncology, 13(9), 887-896. Lancet Publishing Group
Lancet Oncology, 13(9), 887-896. Lancet Publishing Group
Lancet Oncology, 13(9), 887-896. Lancet Publishing Group
Summary Background Little is known about the treatment of breast cancer during pregnancy. We aimed to determine whether treatment for breast cancer during pregnancy is safe for both mother and child. Methods We recruited patients from seven European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b7647fe496adbcbacff74ce6399f762
https://doi.org/10.1016/S1470-2045(12)70261-9
https://doi.org/10.1016/S1470-2045(12)70261-9
Autor:
Christoph Thomssen, Michael Untch, B. Schlehe, Alistair Ring, K. Schwedler, Sibylle Loibl, Patrick Neven, Tanja Fehm, Volkmar Müller, Frédéric Amant, Sileny Han, Nadia Harbeck, M. Bontenbal, Hans Wildiers, Sabine C. Linn, Pieter J. Westenend, Petronella O. Witteveen, J Giermek, Brigitte Rack, Valentina Nekljudova, Gunter von Minckwitz, Kristel Van Calsteren, Ben Van Calster
Publikováno v:
Journal of clinical oncology, 31(20), 2532-+. American Society of Clinical Oncology
Purpose We aimed to determine the prognosis of patients with breast cancer diagnosed during pregnancy (BCP). Patients and Methods In this cohort study, a multicentric registry of patients with BCP (from Cancer in Pregnancy, Leuven, Belgium, and GBG 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a5f5dd3e301b1946f0cf44a8a137376
https://pure.amc.nl/en/publications/prognosis-of-women-with-primary-breast-cancer-diagnosed-during-pregnancy-results-from-an-international-collaborative-study(1bf1fb52-6729-45c1-8364-ca1c9bee9617).html
https://pure.amc.nl/en/publications/prognosis-of-women-with-primary-breast-cancer-diagnosed-during-pregnancy-results-from-an-international-collaborative-study(1bf1fb52-6729-45c1-8364-ca1c9bee9617).html
Autor:
V. Valero, J.P. Crown, M-C Liu, Carla I. Falkson, S. Bensfia, S. Hitier, Arlene Chan, John R. Mackey, J Giermek, N. Xu, Michael F. Press, TA Shiftan, M. Martin, Wolfgang Eiermann, Tamás Pintér, P. Drevot, DJ Slamon, V. Bee-Munteanu, Nicholas J. Robert, M Jasiowka, Tommy Fornander
Publikováno v:
Cancer Research. 76:S5-04
Background: BCIRG-006 was study designed to assess the relative efficacy and safety of two trastuzumab-based regimens compared to a standard (non-trastuzumab) regimen in the adjuvant treatment of early HER2+ breast cancer. We present the final, proto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7af83a45bef631e508f3a85937175c44
https://doi.org/10.1158/1538-7445.sabcs15-s5-04
https://doi.org/10.1158/1538-7445.sabcs15-s5-04
Autor:
K. Van Calsteren, Alistair Ring, Pieter J. Westenend, Brigitte Rack, Valentina Nekljudova, J Giermek, Petronella O. Witteveen, Tanja Fehm, B. Schlehe, Sileny Han, Sabine C. Linn, B. Van Calster, Manfred Kaufmann, M. Bontenbal, Frédéric Amant, Miriam Lenhard, G. von Minckwitz, H. Wildiers, Nadia Harbeck, Patrick Neven, V Müller, S. Loibl
Publikováno v:
Cancer Research. 72:P6-07
Objective: We aimed to add to the limited outcome data on breast cancer during pregnancy (BCP), and compared disease-free survival (DFS), and overall survival (OS) between patients with BCP and breast cancer not diagnosed during pregnancy, adjusted f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::185e1deb85318c8f8e6e0094ec757280
https://doi.org/10.1158/0008-5472.sabcs12-p6-07-05
https://doi.org/10.1158/0008-5472.sabcs12-p6-07-05
Publikováno v:
Journal of Geriatric Oncology. 5:S31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6dc79be9751cc796fba082f21ac7334
https://doi.org/10.1016/j.jgo.2014.09.045
https://doi.org/10.1016/j.jgo.2014.09.045
Autor:
H. Tchórzewska, M. Sikorska, T. Pieńkowski, H. Rudnicka, J. Giermek, Agnieszka Jagiełło-Gruszfeld
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 8:S315-S316
Background Hot flashes are symptoms of vasomotor instability reported in least 50–60% of breast cancer survivors taking tamoxifen. Based on information that venflaxine, one of the newer antidepressants, was able to alleviate hot flashes, we conduct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02022c3bb1a9fd0f9200c4661b3fb9d7
https://doi.org/10.1016/s1507-1367(03)70744-5
https://doi.org/10.1016/s1507-1367(03)70744-5
Autor:
I Scherr, G. von Minckwitz, Tanja Fehm, M. Bontenbal, Alistair Ring, M Heinrigs, Miriam Lenhard, Manfred Kaufmann, Frédéric Amant, Keyur Mehta, H Sileny, J Giermek, S. Loibl
Publikováno v:
Cancer Research. 70:S6-2
Background: To increase the evidence for treatment of breast cancer during pregnancy, the German Breast Group launched a registry (GBG-29/BIG 02-03) for patients with breast cancer diagnosed during pregnancy. Patients: Every pregnant breast cancer pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dfc8ddd74a0e81f6a10c9ffe3917dc7
https://doi.org/10.1158/0008-5472.sabcs10-s6-2
https://doi.org/10.1158/0008-5472.sabcs10-s6-2
Publikováno v:
European Journal of Cancer Supplements. 2:134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51ee770fb8c2a6237f02032216dda6a2
https://doi.org/10.1016/s1359-6349(04)90871-3
https://doi.org/10.1016/s1359-6349(04)90871-3